Significance of HSD17B1 in breast and ovarian cancer - validation of novel HSD17B1 antibodies

dc.contributor.authorKivikoski, Titta
dc.contributor.departmentfi=Biolääketieteen laitos|en=Institute of Biomedicine|-
dc.contributor.facultyfi=Lääketieteellinen tiedekunta|en=Faculty of Medicine|-
dc.contributor.studysubjectfi=Terveyden biotieteet|en=Health Biosciences|-
dc.date.accessioned2017-10-04T11:52:42Z
dc.date.available2017-10-04T11:52:42Z
dc.date.issued2017-10-04
dc.format.contentabstractOnly-
dc.identifier.olddbid160536
dc.identifier.oldhandle10024/143930
dc.identifier.urihttps://www.utupub.fi/handle/11111/5008
dc.language.isoeng-
dc.publisherfi=Turun yliopisto|en=University of Turku|-
dc.source.identifierhttps://www.utupub.fi/handle/10024/143930
dc.titleSignificance of HSD17B1 in breast and ovarian cancer - validation of novel HSD17B1 antibodies-
dc.type.ontasotfi=Pro gradu -tutkielma|en=Master's thesis|-

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Kivikoski Titta.pdf
Size:
52.63 KB
Format:
Adobe Portable Document Format
Description:
Tiivistelmä